How were medical journals and WHO caught out over hydroxychloroquine?
Studies under microscope after Guardian investigation reveals flaws with data from US company Surgisphere
- Governments and WHO changed Covid-19 policy based on suspect data from tiny US company
- Coronavirus – latest updates
- See all our coronavirus coverage
Some scientific papers stop the world in its tracks. In the middle of a raging pandemic, a study in the world’s leading global health journal that seemed to prove President Trump wrong to laud the drug hydroxychloroquine for Covid-19 was always going to have a massive impact. It did. When the paper flagged a higher risk of death on the drug, trials were stopped all over the world, including one by the World Health Organization.
Now it’s in danger of unravelling.